• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS NUT F/FEMUR EXTENS.STEM ALL SZ.NEUTR.; KNEE ENDOPROSTHETICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS NUT F/FEMUR EXTENS.STEM ALL SZ.NEUTR.; KNEE ENDOPROSTHETICS Back to Search Results
Model Number NR400Z
Device Problem Compatibility Problem (2960)
Patient Problem Joint Disorder (2373)
Event Date 12/30/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with as nut f/femur extension.Following information was reported: the original date of surgery was (b)(6) 2016 for a right total knee replacement.The patient was revised on (b)(6) 2019.Black staining of the soft tissue surrounding the implant was noted by the surgeon, followed by extraction of the femoral components.There was also a polyethylene swap; the implants were replaced by new enduro components.A revision surgery was necessary.Additional information was not yet provided nor available.The adverse event is filed under (b)(4).Associated medwatch-reports: 9610612-2019-00912 ((b)(4) nb018z), 9610612-2019-00913 ((b)(4) nr865z), 9610612-2019-00914 ((b)(4) nr295z), 9610612-2019-00916 ((b)(4) nr400z), 9610612-2019-00915 ((b)(4) nr882z), 9610612-2019-00917 ((b)(4) ae-qas-k521-55).
 
Event Description
Pre-op diagnosis: 2019 massive osteolysis to both the fibia and femur of the right knee operative findings: 2019 loosened cement mantles bilaterally with a black staining tissue, in both canals medical treatment provided: tobramycin, antibiotic stimulan pellets, vancomycin.
 
Manufacturer Narrative
Clarification b5: on 19mar2020 additional information was received and 2 complaints were created for the patient, referencing the left knee arthroplasties.(400469058) 2916714-2020-00094.(400469059) 2916714-2020-00102.Associated medwatch-reports: 9610612-2019-00912 (400458621 nb018z); 9610612-2019-00913 (400458623 nr865z); 9610612-2019-00914 (400458624 nr295z); 9610612-2019-00916 (400458625 nr400z); 9610612-2019-00915 (400458626 nr882z); 9610612-2019-00917 (400458627 nb012z); 9610612-2019-01011 (400462509 nr192z); update 8d report.In the meantime a telephone conference was held regarding the "the black staining" with specialists from the product management, an expert from r&d and the attending surgeon from usa.In this telephone conference was agreed that the provided explant components could be disassembled for further investigations.The idea is to separate the peek components for special investigation regarding unusual material abrasion/material inclusion.Due to the special corona situation at that time, this investigation is still outstanding.This 8 d report will be continuously updated with new information/ investigation results.Corrective action a "product safety case (psc)-enduro knee-" was created.
 
Manufacturer Narrative
Clarification: on 24.01.2020 we received the decontaminated products and found out that nb012z(batch 52041408) is the correct item code for complaint 400458627, and the information was updated.Furthermore we created an additional cc(400462509) for item code nr192z (batch 51972344) which we received on 24.01.2020 associated medwatch-reports: 9610612-2019-00912 (400458621 nb018z) 9610612-2019-00913 (400458623 nr865z) 9610612-2019-00914 (400458624 nr295z) 9610612-2019-00916 (400458625 nr400z) report for this case 9610612-2019-00915 (400458626 nr882z) 9610612-2019-00917 (400458627 nb012z) 9610612-2019-01011 (400462509 nr192z).General information we received a complaint regarding "po revision due to staining" from the medical center of plano, plano, usa.The provided device were delivered in a contaminated condition, therefore the components were decontaminated internally according to internal standards.Consequences for the patient post-operative medical intervention was necessary -> revision surgery.Investigation the components were examined visually and microscopically with the digital microscope vhx-5000 keyence eq.-nr.2000024840 and the digital-camera "panasonic dmc tz8".Furthermore this case was discussed with several specialists from the development department and product management.Until there are no valid results from a laboratory investigation regarding tissue samples with the mentioned black staining, it is not possible to determine to origin of the discoloration of the soft tissue.A part of the femoral bone is still fixed on the prosthesis stem.The provided devices show no external damages or abnormalities.The metal surface of the provided explants show no abnormal metal abrasion.During the investigation it was found that the hinge ring moves more sluggishly (moving by hand) than usual.Furthermore it could be determined that the rotation axis stucks absolutely tight in the tibial component, respective in the bearing.The intended movement is no more possible.This is not directly related with the black staining of the tissue.As a next step the locking ring was loosened with the instruments for this purpose.The recess for the rotation axis in the tibial component shows extreme dirt and residues of unknown nature.Regarding this an edx analyses was implemented to identify and verify the mentioned dirt and residues.The result of this analyses is pending.Furthermore it could be found that the peek parts, which are in direct contact with the hinge ring show little damages and abrasions.It is not possible to determine if this peek abrasion/damages is responsible for the mentioned black staining of the soft tissue surrounding the implant.The bearing shows also no abnormal material abrasion.Batch history review the device quality and manufacturing history records have been checked for all available lot numbers and found to be according to our specification valid at the time of production.No similar incidents have been filed with products from these batches.Conclusion and root cause based on the information available and the result of our investigation it is not possible to determine a definitive root cause for the failure.We do not consider that the mentioned failure is product related.Rationale until there are no valid results from a laboratory investigation regarding tissue samples with the mentioned black staining, it is not possible to determine to origin of the discoloration of the soft tissue.It is therefore not possible to determine a definitive root cause for the mentioned black staining.There are no hints for a material problem.According to the quality standard and dhr files a material defect and production error was not found.According to sop sa-de13-m-4-2-04-000-0 (corrective action & preventive action) a capa is not necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS NUT F/FEMUR EXTENS.STEM ALL SZ.NEUTR.
Type of Device
KNEE ENDOPROSTHETICS
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key9643493
MDR Text Key176991199
Report Number9610612-2019-00916
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
PMA/PMN Number
K101815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 04/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNR400Z
Device Catalogue NumberNR400Z
Device Lot Number52213394
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/20/2020
Date Manufacturer Received03/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-